Inspire Medical Systems

ISIN US4577301090

WKN A2JLEP

Market cap (in EUR)

2,419 m

Country

United States

Sector

Healthcare

Dividend yield

0.00%

Overview

Quote

Description

Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. It operates through the United States and All Other Countries geographical segments. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Show more Show less

Healthcare Healthcare Equipment Other Medical Devices United States

Chart

Financials

Key metrics

Market capitalisation, EUR	2,419 m
EPS, EUR	1.32
P/B ratio	4.3
P/E ratio	67.2
Dividend yield	0.00%

Income statement (2024)

Revenue, EUR	742 m
Net income, EUR	49 m
Profit margin	6.67%

What ETF is Inspire Medical Systems in?

There are 4 ETFs which contain Inspire Medical Systems. All of these ETFs are listed in the table below. The ETF with the largest weighting of Inspire Medical Systems is the iShares S&P SmallCap 600 UCITS ETF.

ETF	Weight	Investment focus	Fund size (in m EUR)
iShares S&P SmallCap 600 UCITS ETF	0.13%	Equity United States Small Cap	1,735
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	Equity World Social/Environmental	485
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing	0.00%	Equity North America Social/Environmental	27
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist)	0.04%	Equity United States Small Cap	179

Performance

Returns overview

YTD	-54.94%
1 month	+3.40%
3 months	+23.52%
6 months	-28.23%
1 year	-55.31%
3 years	-66.51%
5 years	-48.65%
Since inception (MAX)	+164.59%
2024	-2.77%
2023	-22.88%
2022	+18.71%
2021	+28.85%

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).